1. What is the ChAdOx1 Vaccine Trial? This trial aims to assess whether the ChAdOx1 vaccine is safe, effective and provides immunity against COVID-19 in adults aged 18 years and above. 2. How long will the vaccine trial run? After starting, the trial will run for 24 months. 3. Why conduct the trial in Kenya? A vaccine which […]